Depression has been linked to the dysfunction of the autonomic nervous
system, which may cause dysregulation of the cardiovascular system. One
promising therapeutic strategy for treating different diseases is inhibiting
the enzyme fatty acid amide hydrolase (FAAH), which increases the
availability of endogenous cannabinoids. We examined the effect of chronic
FAAH inhibition with URB597 treatment on the noradrenaline (NA) content,
synthesis, transport, and degradation in the left ventricle of female and
male rats exposed to chronic unpredictable stress (CUS). CUS decreased the
levels of both NA and dopamine-?-hydroxylase (DBH) protein in male rats and
decreased NA transporter (NET) protein levels in female rats while elevating
monoamine oxidase A (MAO-A) in both sexes. Intraperitoneal URB597
application led to increased expression of DBH in stressed males, as well as
elevated NET protein levels and decreased MAO-A protein levels in the left
ventricle of stressed rats of both sexes. URB597 treatment may have a
beneficial effect on the cardiovascular system in an animal model of
depression with heightened sympathoneural activity.